Blog

Most patients who research ketamine treatment encounter IV infusion clinics first. Intravenous ketamine has the longest track record in clinical research and remains widely available

Ketamine treatment has grown rapidly as a category, and with that growth has come significant variation in how it’s delivered — who administers it, whether

About one in three people with major depressive disorder do not respond adequately to two or more antidepressant trials, a pattern that clinicians call treatment-resistant

If you’re researching ketamine therapy for PTSD in Seattle, you’re probably looking for something that works differently than standard options—or something that can help when

For years, intravenous (IV) ketamine has been considered the gold standard for delivering ketamine in the treatment of depression, anxiety, and PTSD. But as more

Major depressive disorder is a leading cause of disability worldwide, and for many patients, first-line antidepressants are lifesaving. But a substantial minority—often estimated at 20–30%—do